As of 2026-09-28, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (0.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.18 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -115.7%.
The range of the Relative Valuation is (0.47) - (0.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 20.4x | 18.2x |
| Forward P/E multiples | 15.1x - 18.7x | 16.4x |
| Fair Price | (0.47) - (0.54) | (0.50) |
| Upside | -114.9% - -117.0% | -115.7% |
| Date | P/E |
| 2026-07-10 | -110.39 |
| 2026-07-09 | -110.74 |
| 2026-07-08 | -110.74 |
| 2026-07-07 | -109.70 |
| 2026-07-06 | -109.35 |
| 2026-07-02 | -109.70 |
| 2026-07-01 | -109.70 |
| 2026-06-30 | -109.70 |
| 2026-06-29 | -109.35 |